Leerink's John Sullivan Recommends Merck, Pfizer: Video

Feb. 22 (Bloomberg) -- John Sullivan, director of equity research at Leerink Swann & Co., talks w...  More »

Feb. 22 (Bloomberg) -- John Sullivan, director of equity research at Leerink Swann & Co., talks with Bloomberg's Lori Rothman about his recommendation of Pfizer Inc. and Merck & Co. Sullivan, speaking from Boston, also discusses President Barack Obama's new proposals for health-care legislation, which includes the first Medicare tax on unearned income such as capital gains and higher fees on drugmakers, while scaling back a levy on high-end benefits. (Source: Bloomberg)  « Less